Scientists say they were able to predict amyloid status in the brain with high accuracy through blood analysis of two proteins -- amyloid beta and tau phosphorylated at threonine 217, or p-tau217. They say that by adding other information, such as the age of the individuals, the blood tests showed an accuracy rate of over 90 per cent in predicting amyloid buildup. Professor Iwatsubo said new Alzheimer's drugs have recently been approved for use in the early stages of the disease.